Karachi: GlaxoSmithKline Pakistan Limited (GLAXO) reported significant financial growth in its corporate briefing session, highlighting a 7.7% increase in net revenue to PkR65.9 billion for the calendar year 2025. The session also revealed a 53.4% year-on-year surge in profit after tax (PAT), reaching PkR10.0 billion.
According to AKD Securities Limited, GLAXO's gross margins expanded to 37.0% in 2025 from 25.1% in the same period last year, attributed to the deregulation of its non-essential portfolio and measures for profit sustainability. Despite this growth, the company experienced a decline in other income, which fell to PkR1.4 billion from PkR2.8 billion in the previous year. This decrease was largely due to a reduction in promotional allowance, which dropped to PkR615 million from PkR2.1 billion in the same period last year.
The post GlaxoSmithKline Pakistan Reports Increased Profitability Amid Revenue Growth appeared first on Pakistan Business News.